Vedolizumab in the treatment of inflammatory bowel disease: evolving paradigms.
Drugs Context
; 92020.
Article
in En
| MEDLINE
| ID: mdl-32180822
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Drugs Context
Year:
2020
Document type:
Article
Affiliation country:
United kingdom